Hans Lengsfeld
About
In The Last Decade
Hans Lengsfeld
24 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 104
- Molecular Biology 616
- Pharmacology 495
- Endocrinology, Diabetes and Metabolism 265
- Surgery 236
- Physiology 191
Countries citing papers authored by Hans Lengsfeld
This map shows the geographic impact of Hans Lengsfeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Lengsfeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Lengsfeld more than expected).
Fields of papers citing papers by Hans Lengsfeld
This network shows the impact of papers produced by Hans Lengsfeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Lengsfeld. The network helps show where Hans Lengsfeld may publish in the future.
Co-authorship network of co-authors of Hans Lengsfeld
This figure shows the co-authorship network connecting the top 25 collaborators of Hans Lengsfeld. A scholar is included among the top collaborators of Hans Lengsfeld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Lengsfeld. Hans Lengsfeld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 43 | |
| 2 | 24 | |
| 3 | 17 | |
| 4 | 3 | |
| 5 | 58 | |
| 6 | 32 | |
| 7 | 21 | |
| 8 | 29 | |
| 9 | 23 | |
| 10 | 47 | |
| 11 | 148 | |
| 12 | 70 | |
| 13 | 1 | |
| 14 | 45 | |
| 15 | 3 | |
| 16 | 9 | |
| 17 | 289 | |
| 18 | 262 | |
| 19 | Studies on the antiobesity activity of tetrahydrolipstatin, a potent and selective inhibitor of pancreatic lipase. | 70 |
| 20 | 21 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.